Brainsway (BWAY) EBITDA Margin Growth (1y) (2019 - 2026)
Brainsway (BWAY) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 851.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 241.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -313.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 688.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 688.00 |
| Dec 31, 2025 | 259.00 |
| Sep 30, 2025 | 432.00 |
| Jun 30, 2025 | -99.00 |
| Mar 31, 2025 | 336.00 |
| Dec 31, 2024 | 478.00 |
| Sep 30, 2024 | 649.00 |
| Jun 30, 2024 | 2,056.00 |
| Mar 31, 2024 | 5,099.00 |
| Dec 31, 2023 | 6,852.00 |
| Sep 30, 2023 | 8,400.00 |
| Jun 30, 2023 | 690.00 |
| Mar 31, 2023 | -2,453.00 |
| Dec 31, 2022 | -4,299.00 |
| Sep 30, 2022 | -6,456.00 |
| Jun 30, 2022 | 661.00 |
| Mar 31, 2022 | -551.00 |
| Dec 31, 2021 | -1,138.00 |
| Sep 30, 2021 | -555.00 |
| Jun 30, 2021 | -1,714.00 |